Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 74)
20 October 2025
Roche's Gazyva Approved by FDA for Lupus Nephritis Treatment
FDA approves Gazyva for lupus nephritis, showing superior results in trials, offering a new treatment option to prevent kidney disease progression.
20 October 2025
Holcim Acquires Xella
Holcim to acquire Xella, enhancing sustainable walling solutions. Deal valued at EUR 1.85B, EPS and cash flow accretive in year one, closing expected H2 2026.
19 October 2025
NEXTCHEM Conducts Feasibility Study for Waste-to-Methanol Project in Norway
The project explores converting waste to low-carbon methanol at Mongstad, aiming to replace marine fuel and produce Sustainable Aviation Fuel.
19 October 2025
Johnson & Johnson's Subcutaneous Amivantamab Shows 45% Response Rate in Head and Neck Cancer
Subcutaneous amivantamab offers rapid, durable responses in head and neck cancer, with 82% tumor shrinkage and a median response duration of 7.2 months.
19 October 2025
Raludotatug Deruxtecan Shows 50.5% Response in Platinum-Resistant Ovarian Cancer, Reports Daiichi Sankyo and Merck
Raludotatug deruxtecan achieved a 50.5% response rate in phase 2 for platinum-resistant ovarian cancer, with a 5.6 mg/kg dose selected for phase 3.
18 October 2025
Genmab Reports Positive Phase 1/2 Trial Results for Rina-S in Advanced Endometrial Cancer
Rina-S shows 50% response rate in advanced endometrial cancer trial; FDA grants Breakthrough Therapy Designation.
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
18 October 2025
Merck and Eisai: KEYTRUDA and LENVIMA Show 5-Year Survival Benefit in Advanced Endometrial Carcinoma
KEYTRUDA and LENVIMA improve 5-year survival rates in advanced endometrial carcinoma compared to chemotherapy, with consistent results across patient subgroups.
18 October 2025
Merck's KEYTRUDA Plus Chemotherapy Reduces Disease Progression Risk in Platinum-Resistant Ovarian Cancer
KEYTRUDA with chemotherapy shows significant survival benefits in platinum-resistant ovarian cancer, leading to FDA priority review for expanded use.
18 October 2025
Merck: KEYTRUDA and Padcev Cut Bladder Cancer Risks Pre- and Post-Surgery
KEYTRUDA and Padcev improve survival rates in muscle-invasive bladder cancer patients ineligible for cisplatin, showing significant event-free and overall survival benefits.
17 October 2025
Roche Unveils Phase III Data for Vamikibart in Uveitic Macular Edema
Vamikibart shows promise in treating UME, with significant vision improvements in trials, offering a non-steroid alternative with fewer side effects.
17 October 2025
FDA Approves Novo Nordisk's Oral Semaglutide for CV Risk Reduction in High-Risk Type 2 Diabetes Adults
Oral semaglutide reduces major cardiovascular events in high-risk type 2 diabetes patients, showing a 14% risk reduction over 4 years, with consistent safety profile.
17 October 2025
Brenntag Opens Food & Nutrition Innovation Center in Leeds
The Leeds center focuses on R&D for food applications, offering ingredient selection, formulation support, and technical solutions for UK and Ireland food manufacturers.
17 October 2025
Roche's Gazyva/Gazyvaro Gains EU CHMP Nod for Lupus Nephritis
CHMP backs Gazyva/Gazyvaro for lupus nephritis, showing superior renal response in trials. Awaiting European Commission decision.
17 October 2025
Yara's Q3 2025: 38% EBITDA Increase
Focused improvements and cost reductions boost returns, with record production and strong commercial performance. Net income rises, supporting shareholder returns and growth opportunities.
17 October 2025
Heidelberg Materials Launches evoZero, Carbon-Captured Cement in Europe
evoZero, a near-zero carbon cement, is now available in Europe, verified by DNV, supporting sustainable projects like Skøyen Station and DREIHAUS.
17 October 2025
Mitsubishi Gas Chemical and Cirena Agree on Japan Distribution for Long-Chain RNA
MGC and Cirena to negotiate exclusive Japan distribution for long-chain RNA, enhancing MGC's nucleic acid pharmaceutical efforts.
17 October 2025
Mitsubishi Chemical's SoarnoL EVOH Resins Approved for Recyclability in Multilayer Films
RecyClass confirms multilayer films with up to 10% SoarnoL EVOH resins are recyclable with PE flexibles, supporting sustainable packaging and circular economy efforts.
16 October 2025
RIFT and Bureau Veritas Enhance Safety and Compliance
The partnership ensures Iron Fuel Technology meets high safety and compliance standards, supporting its transition from innovation to industrial-scale deployment.
16 October 2025
Carbon Centric Opens Norway's First Carbon Capture Facility
The Rakkestad facility captures CO₂ from waste-to-energy, producing food-grade CO₂. It highlights rapid industrial carbon capture implementation and future expansion plans.
16 October 2025
Solvay-Led Group Delivers Energy Transition Report to Brazil for COP30
The report urges clear policies, funding, and tailored strategies to boost energy transition and highlights private sector's role in reducing emissions.
16 October 2025
E3 Lithium and Axens Sign MOU for Lithium Carbonate Sale and Sorbent Supply
The MOU outlines plans for E3 to supply lithium carbonate and Axens to provide a lithium sorbent, aiming for secure supply chains and future definitive agreements.
16 October 2025
Repsol and Forestalia Launch Major Hybrid Energy Project in Aragon
Hybrid project in Aragon combines 818 MW power plant with 805 MW wind farms, optimizing grid use and supporting a nearby data center with renewable energy.
16 October 2025
BASF Launches High-Purity Isobionics® Natural Lime Flavor Ingredient
Isobionics® Natural alpha-Farnesene 95 offers high purity for lime applications, is fermentation-based, and meets EU/US food regulations. Suitable for beverages, sweets, and citrus flavors.
16 October 2025
Sasol Addresses Homestead Park Pipeline Safety Concerns
Sasol identifies risks from encroaching settlements near its pipeline, collaborates with authorities for solutions, and conducts safety campaigns to ensure public safety.
16 October 2025
Aptar Digital Health's HeroTracker Sense Gains FDA 510(k) Clearance
HeroTracker Sense, a Bluetooth sensor for inhalers, gets FDA clearance, enhancing asthma and COPD management with real-time tracking and personalized support for patients aged 12 and above.
16 October 2025
Johnson & Johnson's AKEEGA® Gets FDA Priority Review for BRCA-Mutated Prostate Cancer
FDA grants Priority Review to AKEEGA® for BRCA-mutated prostate cancer, showing reduced progression risk and improved outcomes in Phase 3 study.
16 October 2025
Merck's KEYNOTE-B96 Trial Shows Improved Survival in Platinum-Resistant Ovarian Cancer
The trial showed improved overall survival with KEYTRUDA in platinum-resistant ovarian cancer, with consistent safety and no new signals. Results to be presented at a future medical meeting.
16 October 2025
Johnson & Johnson's TECVAYLI® and DARZALEX FASPRO® Combo Enhances Survival in Multiple Myeloma
The TECVAYLI® and DARZALEX FASPRO® combo improves progression-free and overall survival in relapsed/refractory multiple myeloma, surpassing standard care in a Phase 3 study.
16 October 2025
Boliden's 2026 AGM Nomination Committee
The Nomination Committee for the 2026 AGM includes members from Swedbank Robur, Alecta, and Handelsbanken. Proposals are due by January 28, 2026. AGM is on April 28, 2026, in Askersund.
16 October 2025
Sasol and Topsoe Partner on E-Fuels Plant in Germany
A new e-fuels plant in Germany will produce 2500 tons annually, using renewable feedstocks, with €130 million funding from the German government. Completion is expected by Q4 2027.
← Previous
Next →
